Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. a review of 80 patients
Matzner, Y.; Benbassat, J.; Polliack, A.
Israel Journal of Medical Sciences 13(8): 797-807
1977
ISSN/ISBN: 0021-2180 PMID: 408296 Document Number: 122901
Document emailed within 1 workday
Related Documents
Zdziarska, B. 1990: Retrospective analysis of patients with multiple myeloma; clinical characteristics and prognostic factors Annales Academiae Medicae Stetinensis 36: 179-194Pick, A.I.; Tamir, R.; Vana, D.; Duczyminer-Kahana, M.; Weiss, H.; Lurie, H.; Dawidowich, J.; Meyerson, E.; Gelernter, I. 1990: Prognostic factors in multiple myeloma Harefuah 118(8): 437-442
Peest, D. 1998: Prognostic factors and standard therapy of multiple myeloma Praxis 87(25-26): 874-878
Pasqualetti, P.; Colantonio, D.; Collacciani, A.; Casale, R.; Natali, G. 1991: Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications Panminerva Medica 33(2): 93-110
Talic, R.F.; El Faqih, S.R. 1998: Survival and prognostic factors in renal cell carcinoma in Saudi patients: A ten year review Saudi Medical Journal 19(2): 170-173
Pasqualetti, P.; Colantonio, D.; Casale, R.; Lorenzetti, G.; Natali, G. 1989: Prognostic factors in multiple myeloma. Selection using multivariate analysis Recenti Progressi in Medicina 80(10): 543-546
Chavynchak, R.B.; Rekhtina, I.G. 2008: Prognostic factors in multiple myeloma complicated with renal failure Terapevticheskii Arkhiv 80(1): 84-88
Bladé, J.; Rozman, C. 1984: Multiple myeloma: analysis of prognostic factors and classification by stages Sangre 29(5): 918-926
Takei, T.; Coles, M. 1996: Treatment of pathologic fracture and surgical value of prognostic factors in multiple myeloma International Surgery 81(4): 403-406
Gardella, S.; Cervantes, F.; Bladé, J.; Brugués, R.; Rozman, C. 1982: Acute myeloproliferative syndrome after alkylating agent treatment in a case of multiple myeloma Medicina Clinica 79(4): 185-188
Di Filippo, F.; Giacomini, P.; Rossi, C.R.; Santinami, M.; Anzà, M.; Garinei, R.; Perri, P.; Botti, C.; Di Angelo, P.; Sofra, C.; Pasqualoni, R.; Sperduti, I.; Cavaliere, F.; Di Filippo, S.; Corrias, F.; Armenti, A.; Ferraresi, V.; Ginebri, A. 2009: Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusion In Vivo 23(2): 347-352
Spasov, E.; Goranova, V. 1998: Prognostic assessment of the Durie and Salmon staging system in patients with multiple myeloma Folia Medica 40(3b Suppl 3: 121-123
Li, J.; Zhao, Y.; Luo, S.-K.; Huang, B.-H.; Zhang, G.-C.; Peng, A.-H.; Zheng, D.; Su, C.; Xu, D.-R.; Tong, X.-Z.; Gu, J.-L.; Ding, Y. 2008: The clinical features, chemotherapy responses and survival of 223 patients with newly diagnosed multiple myeloma Zhonghua Yi Xue Za Zhi 88(30): 2140-2143
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Battikh, M.H.; Ben Sayah, M.M.; Joobeur, S.; Rouetbi, N.; Ben Salem, K.; Daami, M.; Maatallah, A.; Raham, W.; Farhat, C.; El Kamel, A. 2004: Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases La Tunisie Medicale 82(9): 843-848
Basit, A.; Siddiqui, N.; Hameed, A.; Muzaffar, N.; Athar, S. 2014: Factors affecting outcome of patients with multiple myeloma Journal of Ayub Medical College Abbottabad: Jamc 26(3): 376-379
Laohavinij, S.; Maneechavakajorn, J.; Techatanol, P. 2010: Prognostic factors for survival in colorectal cancer patients Journal of the Medical Association of Thailand 93(10): 1156-1166
Wang, Q.-x.; Yan, Y.-p.; Ji, Z.-h.; Ni, Q.-r.; Song, Y.-p.; Li, S.-t.; Xie, J.; Ren, J.-j.; Guo, L.; Dai, J.-q. 2013: Study on the quality of life and its related factors on patients with multiple myeloma Zhonghua Liu Xing Bing Xue Za Zhi 34(12): 1233-1236
Vashakidze, N.; Mebonia, N.; Kereselidze, M.; Gvamichava, R.; Zhizhilashvili, S. 2018: Effect of Selected Prognostic and Risk Factors on Survival of Women with Breast Cancer in Georgia Georgian Medical News 279: 23-28
Ishida, R.; Utsumi, K.R.; Takahashi, T. 1989: Sister-chromatid exchanges (SCEs), cell survival and mutation in HeLa s3 cells with different sensitivity to alkylating agents; evidence that SCE induction and cell survival or mutation induction are dissociable Mutation Research 215(1): 69-77